Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in Adults With Obsessive-Compulsive Disorder
NCT01100255Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Apr 2010
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in obsessive compulsive disorder (OCD), sponsored by New York State Psychiatric Institute. Started Apr 2010; status: completed.
02
Drugs
ketamine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT01100255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100255.